Overview
RLMD market data
Price History
RLMD price chart · 1M
- O
- 4.36
- H
- 4.44
- L
- 4.34
- C
- 4.43
- Vol
- 71,352.00
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $4.36
- Previous Close
- $4.38
- Day High
- $4.44
- Day Low
- $4.34
- 52 Week High
- $7.66
- 52 Week Low
- $4.29
- 7 Day Return
- +2.31%
- 30 Day Return
- -18.57%
- 90 Day Return
- -22.42%
- 1 Year Return
- -39.77%
- Daily Notional Volume
- $316.1K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.45 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.58 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -500.0% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $1.13 – $8.00 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $466.1M · P/B 4.09.
Company News
7 captured
Relmada Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare ConferenceGlobenewswire Inc ·
Relmada Therapeutics Joins Russell 2000® and Russell 3000® IndexesGlobenewswire Inc ·